Search Results - "Mylonakis, Sophia C."

The association of obesity with health insurance coverage and demographic characteristics: a statewide cross-sectional study by Mylona, Evangelia K., Benitez, Gregorio, Shehadeh, Fadi, Fleury, Elvira, Mylonakis, Sophia C., Kalligeros, Markos, Mylonakis, Eleftherios

“…We evaluated the statewide burden of obesity and its complications among government and state funded programs (Medicare and Medicaid) and commercial…”
Get full text

Circulating hormones in biopsy-proven steatotic liver disease and steatohepatitis: A Multicenter Observational Study by Valenzuela-Vallejo, Laura, Chrysafi, Pavlina, Kouvari, Matina, Guatibonza-Garcia, Valentina, Mylonakis, Sophia C., Katsarou, Angeliki, Verrastro, Ornella, Markakis, Georgios, Eslam, Mohammed, Papatheodoridis, Georgios, Mingrone, Geltrude, George, Jacob, Mantzoros, Christos S.

“…The role of metabolic/inflammatory hormonal systems in metabolic dysfunction associated steatotic liver disease (MASLD) remains to be fully elucidated. To…”
Get full text

Liver biopsy-based validation, confirmation and comparison of the diagnostic performance of established and novel non-invasive steatotic liver disease indexes: Results from a large multi-center study by Kouvari, Matina, Valenzuela-Vallejo, Laura, Guatibonza-Garcia, Valentina, Polyzos, Stergios A., Deng, Yixiang, Kokkorakis, Michail, Agraz, Melih, Mylonakis, Sophia C., Katsarou, Angeliki, Verrastro, Ornella, Markakis, Georgios, Eslam, Mohammed, Papatheodoridis, Georgios, George, Jacob, Mingrone, Geltrude, Mantzoros, Christos S.

“…Non-invasive tools (NIT) for metabolic-dysfunction associated liver disease (MASLD) screening or diagnosis need to be thoroughly validated using liver…”
Get full text

Apolipoprotein C-III in association with metabolic-dysfunction associated steatotic liver disease: A large, multicenter study by Kouvari, Matina, Valenzuela-Vallejo, Laura, Guatibonza-Garcia, Valentina, Verrastro, Ornella, Axarloglou, Evangelos, Mylonakis, Sophia C., George, Jacob, Papatheodoridis, Georgios, Mingrone, Geltrude, Mantzoros, Christos S.

“…The available literature on the effect of apolipoprotein C-III (ApoC-III) inhibition in MASLD reveals inconsistencies. The aim of the present work was to…”
Get full text

The first external validation of the Dallas steatosis index in biopsy-proven Non-alcoholic fatty liver Disease: A multicenter study by Kouvari, Matina, Mylonakis, Sophia C., Katsarou, Angeliki, Valenzuela-Vallejo, Laura, Guatibonza-Garcia, Valentina, Kokkorakis, Michail, Verrastro, Ornella, Angelini, Giulia, Markakis, Georgios, Eslam, Mohammed, George, Jacob, Papatheodoridis, Georgios, Mingrone, Geltrude, Mantzoros, Christos S.

“…A new non-invasive tool (NIT) for non-alcoholic fatty liver disease (NAFLD) proposed in 2022 by the multi-ethnic Dallas Heart Study, i.e. the Dallas Steatosis…”
Get full text

How Comorbidities Affect Hospitalization from Influenza in the Pediatric Population by Mylonakis, Sophia C, Mylona, Evangelia K, Kalligeros, Markos, Shehadeh, Fadi, Chan, Philip A, Mylonakis, Eleftherios

“…Influenza is a contagious respiratory illness and can lead to hospitalization and even death. Understanding how comorbidities affect the severity of influenza…”
Get full text